Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice. Oral semaglutide: Frontiers in Endocrinology (2021)
We'll get back to you as soon as possible, within 24 hours on weekdays
This medication reduces hunger, so if youre busy and skip meals, nausea can kick in Eating every four to five hours helps prevent your stomach from being empty. Semaglutide (Wegovy) is approved by the US Food and Drug Administration (FDA) for weight loss and is the most accessible
When GLP-1 receptors are activated, four things happen: appetite is suppressed through signals in the hypothalamus and brainstem, gastric emptying slows (keeping you full longer), glucose-dependent insulin release is enhanced, and inappropriate post-meal glucagon release is suppressed
For a medical emergency, call 911 or go to the nearest emergency room
Clinical Focus on GLP-1 Agonists in Type 2 Diabetes Mellitus Exenatide or liraglutide have a role in the treatment of T2DM as monotherapy or in addition to oral antidiabetic drugs